Gut microbiome and immune support

Lactobacillus acidophilus

L. acidophilus is one of the most studied probiotic strains, with evidence for improving GI symptoms, lactose tolerance, and immune parameters. Effect sizes are modest and strain-specific.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Modest improvement in GI symptoms and immune markers; highly strain-dependent
Safety
Low Risk

Immunocompromised individuals should consult a physician before probiotic use; quality and CFU count vary significantly by brand.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
1-10 billion CFU
Timing
With meals
Protocol Duration in Studies
4-8 weeks for symptom endpoints; longer for microbiome stabilization

Multi-strain formulations typically outperform single-strain products for general gut health.

Best Fit Profiles

  • GI symptom management, post-antibiotic microbiome recovery, and immune baseline support

Source Links